Octagon Capital Advisors’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$11.6M	Buy	+266,000	New	+$11.6M	2.55%	19
2021 Q3	–	Sell	-100,000	Closed	-$4.85M	–	32
2021 Q2	$4.85M	Buy	+100,000	New	+$4.85M	1%	26